XML 42 R22.htm IDEA: XBRL DOCUMENT

Segment Data (Tables)

9 Months Ended

Jun. 30, 2012

Financial information for the Company's segments


	Three Months Ended June 30,						Nine Months Ended June 30,
	2012			2011			2012			2011
Revenues (A)
Medical	$	1,070,076		$	1,044,836		$	3,041,660		$	2,952,713
Diagnostics		642,250			631,359			1,893,012			1,838,429
Biosciences		268,204			275,694			806,539			804,714

	$	1,980,530		$	1,951,889		$	5,741,211		$	5,595,856

Segment Operating Income
Medical	$	323,868		$	324,170		$	862,856		$	887,080
Diagnostics		173,535			164,293			496,950			481,322
Biosciences		67,157			64,472			199,582			202,403

Total Segment Operating Income		564,560			552,935			1,559,388			1,570,805
Unallocated Items (B)		(146,019	)		(117,765	)		(448,879	)		(346,792	)

Income from Continuing Operations Before Income Taxes	$	418,541		$	435,170		$	1,110,509		$	1,224,013

(A)	Intersegment revenues are not material.

(B)	Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.

Revenues by Organizational Units


	Three Months Ended June 30,				Nine Months Ended June 30,
	2012		2011		2012		2011
Revenues by Organizational Units
BD Medical
Medical Surgical Systems	$	531,771	$	529,018	$	1,573,020	$	1,546,334
Diabetes Care		232,675		220,184		677,839		641,826
Pharmaceutical Systems		305,630		295,634		790,801		764,553

	$	1,070,076	$	1,044,836	$	3,041,660	$	2,952,713

BD Diagnostics
Preanalytical Systems	$	333,454	$	330,326	$	973,389	$	949,194
Diagnostic Systems		308,796		301,033		919,623		889,235

	$	642,250	$	631,359	$	1,893,012	$	1,838,429

BD Biosciences
Cell Analysis (1)	$	268,204	$	275,694	$	806,539	$	804,714

	$	268,204	$	275,694	$	806,539	$	804,714

	$	1,980,530	$	1,951,889	$	5,741,211	$	5,595,856

(1)	Cell Analysis consists of the Cell Analysis unit and the Advanced Bioprocessing platform.

Revenues by geographic areas


	Three Months Ended June 30,				Nine Months Ended June 30,
	2012		2011		2012		2011
Total Revenues
United States	$	836,535	$	827,445	$	2,463,858	$	2,433,109
International		1,143,995		1,124,444		3,277,353		3,162,747

	$	1,980,530	$	1,951,889	$	5,741,211	$	5,595,856

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details